Clinical Trial

Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)

Study acronym: CACsHIVMex
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The risk of atherosclerotic cardiovascular disease is increased in people with HIV infection, including young patients and those with few traditional cardiovascular risk factors. The increased risk of cardiovascular disease among people living with HIV is due to accelerated atherosclerosis, caused by chronic inflammation and immune dysregulation. The measurement of coronary calcium using plain computed tomography is a subclinical indicator of coronary atherosclerosis and is associated with the risk of cardiovascular events and mortality in the general population.
Trial Details
NCT Number NCT07662161
Lead Sponsor Instituto Mexicano del Seguro Social
Conditions HIV - Human Immunodeficiency Virus
Enrollment 384 participants
Start Date 2026-07-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2030-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-23